Related Experiment Video
Updated: May 5, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Pneumococcal meningitis and endotoxemia: A cross-sectional clinical study
Sylvie Nguyen1, Jeanne Godon2, Jean-Paul Pais de Barros3
1Lipness Team, INSERM Research Centre LNC-UMR1231 and LabEx LipSTIC, University of Burgundy, Dijon, France.
Introduction:
Lipopolysaccharide (LPS) is a major virulence factor during both meningococcal and Haemophilus influenzae meningitis. Pneumococcus does not produce LPS but could be responsible for bacterial digestive translocation as a consequence of sepsis. We addressed this question in the context of pneumococcal meningitis.
Methods:
A cross-sectional study on 24 patients with pneumococcal meningitis (20 (83%) admitted in intensive care unit, 4 (17%) with septic shock) and 34 prospectively-enrolled healthy volunteers. Interleukin 6 and C-reactive proteins plasma concentrations were measured as markers of systemic inflammation. Endotoxemia was measured using mass spectrometry (LC-MS/MS) for detection of molecules bound to the lipid A, namely 3-OH fatty acids.
Results:
Meningitis patients had significantly higher levels of plasma C-reactive protein (237 (74-373) vs. 2 (2-2) mg/l, p < 0.001 and interleukin 6 (43 (13-128) vs. 4.6 (4.6-16.6) pg/ml; p < 0.001) than healthy volunteers. However, we observed no significant difference in plasma lipopolysaccharide concentrations between patients and healthy volunteers (674 (554-896) vs. 668 (623-777) pmol/ml; p = 0.546).
Conclusions:
Our results suggest that LPS is not a key determinant of the excessive inflammation associated with severe forms of pneumococcal meningitis.
Insights
Lipopolysaccharide (LPS) is not a key factor in pneumococcal meningitis inflammation. Studies show no significant difference in LPS levels between meningitis patients and healthy individuals, despite higher inflammatory markers in patients.
Area of Science:
- Infectious Diseases
- Immunology
- Microbiology
Background:
- Lipopolysaccharide (LPS) is a critical virulence factor in meningococcal and Haemophilus influenzae meningitis.
- Pneumococcus, unlike other bacteria, does not produce LPS but may contribute to bacterial translocation during sepsis.
- The role of LPS in pneumococcal meningitis-associated inflammation requires investigation.
Purpose of the Study:
- To investigate the presence and role of lipopolysaccharide (LPS) in pneumococcal meningitis.
- To determine if LPS contributes to the systemic inflammation observed in pneumococcal meningitis.
Main Methods:
- Cross-sectional study of 24 pneumococcal meningitis patients and 34 healthy volunteers.
- Measurement of plasma interleukin-6 and C-reactive protein as systemic inflammation markers.
- Quantification of plasma LPS using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Main Results:
- Pneumococcal meningitis patients exhibited significantly elevated C-reactive protein and interleukin-6 levels compared to healthy controls.
- No significant difference was found in plasma lipopolysaccharide concentrations between meningitis patients and healthy volunteers.
- These findings indicate that LPS is not a primary driver of inflammation in severe pneumococcal meningitis.
Conclusions:
- Lipopolysaccharide (LPS) does not appear to be a significant determinant of excessive inflammation in severe pneumococcal meningitis.
- The inflammatory response in pneumococcal meningitis is likely driven by factors other than LPS.
- Further research is needed to elucidate the specific mechanisms of inflammation in pneumococcal meningitis.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Pneumonia I: Introduction

